| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $24.11 ▲ +1.15% | Yesterday | $23.72 ▼ -0.48% | Tomorrow's Definium Therapeutics Inc. Common Shares (DFTX) setup is anchored to $23.84 and targets $24.11 (+1.15%). The near-term read is upside; watch $24.56 / $23.12 because daily realized volatility is about 5.93%. |
Tomorrow's Definium Therapeutics Inc. Common Shares (DFTX) setup is anchored to $23.84 and targets $24.11 (+1.15%). The near-term read is upside; watch $24.56 / $23.12 because daily realized volatility is about 5.93%. | ||||
| Week | $24.69 ▲ +3.58% | Last Week | $23.48 ▼ -1.50% | The 7-day Definium Therapeutics Inc. Common Shares model moves from $23.48 to $24.69 (+3.58%). It gives upside momentum context for this stock, so breaks around $24.56 / $23.12 matter more than a single tick. |
The 7-day Definium Therapeutics Inc. Common Shares model moves from $23.48 to $24.69 (+3.58%). It gives upside momentum context for this stock, so breaks around $24.56 / $23.12 matter more than a single tick. | ||||
| Month | $25.66 ▲ +7.61% | Last Month | $23.08 ▼ -3.20% | The 1-month Definium Therapeutics Inc. Common Shares target is $25.66 (+7.61%), compared with the live reference near $23.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Definium Therapeutics Inc. Common Shares target is $25.66 (+7.61%), compared with the live reference near $23.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $27.10 ▲ +13.67% | Last Year | $22.47 ▼ -5.74% | The 1-year Definium Therapeutics Inc. Common Shares scenario points to $27.10 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Definium Therapeutics Inc. Common Shares scenario points to $27.10 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $30.48 ▲ +27.86% | 5 Years Ago | $21.05 ▼ -11.70% | The 5-year Definium Therapeutics Inc. Common Shares view is $30.48 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Definium Therapeutics Inc. Common Shares view is $30.48 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $23.84 | Mid |
| Daily Change | +2.85% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 63% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $23.84 | Daily Change | +2.85% |
| Market Cap | $2.35B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.